Alkermes Plc (NASDAQ:ALKS)
| 17.62 Delayed Data As of Jan 24 |  -0.58 / -3.19%Today’s Change | 17.11 Today|||52-Week Range 37.75 | -13.63% Year-to-Date |
Latest ALKS News | Press Releases
No recent news for Alkermes Plc.
Today’s Trading
| Previous close | 18.20 |
| Today’s open | 18.20 |
| Day’s range | 17.25 - 18.46 |
| Volume | 1,928,235 |
| Average volume (3 months) | 1,517,085 |
| Market cap | $2.8B |
Data as of 4:00pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | +12.81% |
| Earnings growth (this year) | -10.31% |
| Earnings growth (next 5 years) | +26.55% |
| Revenue growth (last year) | +21.13% |
| P/E ratio | NM |
| Price/Sales | 4.18 |
| Price/Book | 2.35 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BHVNBiohaven Pharmaceuti... | -1.47 | -2.63% |
| KRTXKaruna Therapeutics ... | 0.00 | 0.00% |
| APLSApellis Pharmaceutic... | -0.99 | -2.34% |
| ---- |
Data as of 6:30pm ET, 01/24/2020
Financials
| Next reporting date | February 17, 2020 |
| EPS forecast (this quarter) | $0.65 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | -$139.3M |
| Net profit margin | -12.73% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
